2seventy bio, Inc. (TSVT) Tops Q3 EPS by 36c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($1.40), $0.36 better than the analyst estimate of ($1.76). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ecolab pops as Citi sees improving setup into Q2 earnings